The additive effects of smoking and hypertension: More reasons to help your patients kick the habit

Postgraduate Medicine

Volumn 100, Issue 5, 1996, Pages

  Kochar, Mahendr S ^a   Bindra, Rajvinder S ^b  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLONIDINE; DOXAZOSIN; PROPRANOLOL;

ANTIHYPERTENSIVE THERAPY; BLOOD VESSEL WALL; BODY WEIGHT; CARDIOVASCULAR EFFECT; CLINICAL TRIAL; CORONARY RISK; DOCTOR PATIENT RELATION; DROWSINESS; DRUG EFFICACY; HEMOSTASIS; HUMAN; HYPERTENSION; LIPID METABOLISM; MALIGNANT HYPERTENSION; REVIEW; SMOKING; SMOKING CESSATION; THROMBOCYTE FUNCTION; XEROSTOMIA;

EID: 10544232280     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1996.11.114     Document Type: Review

References (13)

1. Elders MJ, Perry CL, Eriksen MP, et al. The report of the Surgeon General: preventing tobacco use among young people. Am J Public Health 1994;84(4):543-7
2. Kannel WB, Higgins M. Smoking and hypertension as predictors of cardiovascular risk in population studies. J Hypertens Suppl 1990; 8(5):S3-8
3. De Cesaris R, Ranieri G, Filitti V, et al. Cardiovascular effects of cigarette smoking. Cardiology 1992:81(4-5):233-7
4. Groppelli A, Giorgi DM, Omboni S, et al. Persistent blood pressure increase induced by heavy smoking. J Hypertens 1992;10(5):495-9
5. Khosla S, Laddu A, Ehrenpreis S, et al. Cardiovascular effects of nicotine: relation to deleterious effects of cigarette smoking. (Editorial) Am Heart J 1994;127(6):1669-72
6. Kannel WB, D'Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study. Am Heart J 1987;113(4):1006-10
7. Miller NE, Hammett F, Saltissi S, et al. Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. Br Med J (Clin Res Ed) 1981;282(6278):1741-4
8. Dollery C, Brennan PJ. The Medical Research Council Hypertension Trial: the smoking patient. Am Heart J 1988:115(1 Pt 2):276-81
9. Groppelli A, Omboni S, Parati G, et al. Blood pressure and heart rate response to repeated smoking before and after beta-blockade and selective alpha 1 inhibition. J Hypertens 1990:8(5 Suppl):S35-40
10. Glassman AH, Stetner F, Walsh BT, et al. Heavy smokers, smoking cessation, and clonidine:: results of a double-blind, randomized trial. JAMA 1988;259(19):2863-6
11. Wilhelmsen L. Antismoking counselling: methods of helping hypertensive patients to stop smoking. J Hypertens 1990;8(Suppl 5):S25-8
12. US Department of Health and Human Services. The physician's guide, how to help your hypertensive patients stop smoking. Bethesda: National High Blood Pressure Education Program, National Heart, Lung, and Blood Institute, 1983 April; NIH publication No. 83-1271
13. Houston TP, Eriksen MP, Fiore M, et al. How to help patients stop smoking: guidelines for diagnosis and treatment of nicotine dependence. Chicago: Am Medical Assoc, 1994